China Resources Double-Crane Pharmaceutical Co., Ltd. is a high-risk pharmaceutical company in China, specializing in the development, manufacturing, and marketing of a wide range of medical products across various fields. With an ESG score of 32.4, the company focuses on sustainability and governance practices in the pharmaceutical industry.